Ylide-functionalised phosphanes for use in metal complexes and homogeneous catalysis

US10940470B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10940470-B2
Application numberUS-201816636962-A
CountryUS
Kind codeB2
Filing dateAug 8, 2018
Priority dateAug 8, 2017
Publication dateMar 9, 2021
Grant dateMar 9, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to ylide-functionalized phosphane ligands, the production of same and use in transition metal compounds, as well as the use of same as catalysts in organic reactions.

First claim

Opening claim text (preview).

The invention claimed is: 1. Metal complexes having phosphane ligands of formula (I) wherein On is a phosphonium group —P(R 3 R 4 R 5 ), in which R 3 , R 4 and R 5 are independently selected from the group consisting of C 1-6 alkyl groups, C 4-10 cycloalkyl groups, C 6-10 aryl groups, X is selected from the group consisting of linear, branched-chain or cyclic C 1-6 alkyl groups, C 6-10 aryl groups, mono- or polyunsaturated linear, branched-chain or cyclic C 2-6 alkenyl groups, a trialkylsilyl (—SiR 3 R 4 R 5 ), arylsulfonyl group, and R 1 and R 2 are C 6-10 aryl groups or C 1-6 alkyl and cycloalkyl groups, with the proviso that ligands where R 1 and R 2 are phenyl, On is triphenylphosphine (PPh 3 ) and X is phenyl or methyl are excluded. 2. The metal complexes according to claim 1 , wherein R 3 , R 4 and R 5 are independently selected from the group consisting of methyl, ethyl, butyl, cyclohexyl, phenyl, and combinations thereof. 3. The metal complexes according to claim 1 , wherein X is selected from the group consisting of methyl, ethyl, cyclohexyl, phenyl, p-tolyl, trimethylsilyl, p-tolylsulfonyl, or combinations thereof. 4. The metal complexes according to claim 1 , wherein said complex is a palladium allyl complex having the following structure (V) wherein X′ is an anion, Y is On-C—X, R 33 , R 34 and R 35 are independently selected from H, alkyl, aryl and heteroaryl groups that may be unsubstituted or substituted with functional groups; or at least two of R 33 , R 34 and R 35 form a carbocyclic ring with 5 to 14 carbon atoms, Ar represents a substituted or unsubstituted aryl group. 5. The metal complexes according to claim 4 , wherein R 33 , R 34 and R 35 are independently selected from linear, branched-chain or cyclic C 1-10 alkyl groups, the aryl groups are selected from C 6-14 aryl groups, the alkenyl groups are selected from mono- or polyunsaturated linear, branched-chain or cyclic C 2-10 alkenyl groups, and the heteroaryl groups are selected from C 6-14 heteroaryl groups, wherein all of the groups mentioned are optionally substituted with functional groups; or at least two of R 33 , R 34 and R 35 form a carbocyclic ring that is a C 4-10 cycloalkyl group, or a C 6-14 aryl group, optionally substituted with one or more functional groups; and Ar are selected from C 6-14 aryl groups and the heteroaryl groups are selected from C 6-14 heteroaryl groups, wherein all of the groups mentioned are optionally substituted with functional groups; and the functional groups are selected from C 1-6 alkyl groups, C 6-10 aryl, halogen, hydroxy, cyano, alkoxy, amino, or mercapto. 6. The metal complexes of claim 1 , wherein the metal of the metal complex is selected from the group consisting of copper, silver, gold, platinum, palladium, nickel, and combinations thereof. 7. A process for performing a coupling reaction containing the steps of providing a reaction mixture containing at least a substrate, coupling partner, and the metal complex according to claim 1 ; and reacting said substrate with said coupling partner in the presence of the metal complex or its derivative to form a coupling product. 8. The process according to claim 7 , wherein the metal of said metal complex is a precious metal or a transition metal. 9. The process according to claim 7 , wherein the metal of said metal complex is a metal of group 10 or 11 of the Periodic Table of the elements. 10. The process according to claim 7 , wherein the metal of said metal complex is selected from the group consisting of copper, silver, gold, platinum, palladium, nickel, and combinations thereof.

Assignees

Inventors

Classifications

  • Nickel compounds · CPC title

  • Palladium compounds · CPC title

  • C07F9/54Primary

    Quaternary phosphonium compounds · CPC title

  • Gold compounds · CPC title

  • Formation or introduction of functional groups containing nitrogen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10940470B2 cover?
The invention relates to ylide-functionalized phosphane ligands, the production of same and use in transition metal compounds, as well as the use of same as catalysts in organic reactions.
Who is the assignee on this patent?
Umicore Ag & Co Kg
What technology area does this patent fall under?
Primary CPC classification C07F9/54. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).